These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20665616)

  • 21. Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues.
    Singh AJ; Razzak M; Teesdale-Spittle P; Gaitanos TN; Wilmes A; Paterson I; Goodman JM; Miller JH; Northcote PT
    Org Biomol Chem; 2011 Jun; 9(12):4456-66. PubMed ID: 21512693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
    Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
    ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
    Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
    Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.
    Wilmes A; Rawson P; Peng L; McLauchlan D; Northcote PT; Jordan TW; Miller JH
    Invest New Drugs; 2011 Aug; 29(4):544-53. PubMed ID: 20107863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
    Kanakkanthara A; Northcote PT; Miller JH
    Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.
    Chan A; Singh AJ; Northcote PT; Miller JH
    Invest New Drugs; 2015 Jun; 33(3):564-74. PubMed ID: 25822110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking and molecular dynamics studies of the binding between Peloruside A and tubulin.
    Liao SY; Mo GQ; Chen JC; Zheng KC
    J Enzyme Inhib Med Chem; 2014 Oct; 29(5):702-9. PubMed ID: 24156744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the β-tubulin binding site for peloruside A confer resistance by targeting a cleft significant in side chain binding.
    Begaye A; Trostel S; Zhao Z; Taylor RE; Schriemer DC; Sackett DL
    Cell Cycle; 2011 Oct; 10(19):3387-96. PubMed ID: 21926482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments.
    Churchill CD; Klobukowski M; Tuszynski JA
    Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing the laulimalide-peloruside binding site using site-directed mutagenesis of TUB2 in S. cerevisiae.
    Hanna R; Maass DR; Atkinson PH; Northcote PT; Teesdale-Spittle PH; Bellows DS; Miller JH
    Mol Biosyst; 2014 Jan; 10(1):110-6. PubMed ID: 24161989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
    Das V; Miller JH
    Eur J Neurosci; 2012 Jun; 35(11):1705-17. PubMed ID: 22594877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical modulation of microtubule structure through the laulimalide/peloruside site.
    Estévez-Gallego J; Álvarez-Bernad B; Pera B; Wullschleger C; Raes O; Menche D; Martínez JC; Lucena-Agell D; Prota AE; Bonato F; Bargsten K; Cornelus J; Giménez-Abián JF; Northcote P; Steinmetz MO; Kamimura S; Altmann KH; Paterson I; Gago F; Van der Eycken J; Díaz JF; Oliva MÁ
    Structure; 2023 Jan; 31(1):88-99.e5. PubMed ID: 36462501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
    Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
    Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis and absolute configuration of the novel microtubule-stabilizing agent peloruside A.
    Liao X; Wu Y; De Brabander JK
    Angew Chem Int Ed Engl; 2003 Apr; 42(14):1648-52. PubMed ID: 12698467
    [No Abstract]   [Full Text] [Related]  

  • 35. Enantioselective total synthesis of peloruside A: a potent microtubule stabilizer.
    Ghosh AK; Xu X; Kim JH; Xu CX
    Org Lett; 2008 Mar; 10(5):1001-4. PubMed ID: 18247632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peloruside, laulimalide, and noscapine interactions with beta-tubulin.
    Gajewski MM; Alisaraie L; Tuszynski JA
    Pharm Res; 2012 Nov; 29(11):2985-93. PubMed ID: 22733149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C.
    Hood KA; Bäckström BT; West LM; Northcote PT; Berridge MV; Miller JH
    Anticancer Drug Des; 2001; 16(2-3):155-66. PubMed ID: 11962513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.
    Singh AJ; Xu CX; Xu X; West LM; Wilmes A; Chan A; Hamel E; Miller JH; Northcote PT; Ghosh AK
    J Org Chem; 2010 Jan; 75(1):2-10. PubMed ID: 19957922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse Model.
    Meyer CJ; Krauth M; Wick MJ; Shay JW; Gellert G; De Brabander JK; Northcote PT; Miller JH
    Mol Cancer Ther; 2015 Aug; 14(8):1816-23. PubMed ID: 26056149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
    Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
    Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.